INTERPRETATION OF CHANGES IN QUANTITATIVE RATIO OF NEUROTROPIC AUTOANTIBODIES IN PATIENTS WITH COVID-19

Иноятова Фируза Хидоятовна, Рахматуллаева Гулнора Кутбиддиновна, Вахобова Нигина Анорбековна, Абдувалиев Абдурахмон Рустам угли, Миркомилов Элдор Миркодир угли, Салиходжаева Умида Шакировна, Каримов Зохид Бахтиёрович, Исмоилов Хаётжон Уктамжон угли, Султонов Эркин Ёкубжон угли

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research · 2022-yil

Annotatsiya

COVID-19 is a new disease in the history of mankind, the pathogenesis of the development of clinical symptoms, the early and late complications of which are not well understood. Careful observation of patients with COVID-19 has shown that the symptoms of damage to the nervous system in this disease can be varied, however, very little is known about the long-term consequences of COVID-19. Despite a significant variety of methods for studying the nervous system, the effectiveness of most of them remains low in terms of detecting the earliest preclinical changes. It is appropriate to pose the question, is there a method that can indicate with great accuracy that the pathological process has started and there is a tendency for the development of a certain disease even before the appearance of changes in the indications of the traditionally used methods of early diagnosis of this disease? When, under the influence of various etiological factors, the process of cell destruction is accelerated, the immune system begins to produce more autoantibodies so that the clearance process proceeds at an appropriate rate. This is a very important point, since it is the increase in the levels of specific autoantibodies that is the very early and sensitive marker indicating the start of the pathological process long before the appearance of biochemical preclinical shifts. The ELI-Neuro-Test method of immunochemical analysis makes it possible to comprehensively assess the state of neurotransmitter systems and, long before the appearance of neurological or psychiatric symptoms, with a high probability of predicting diseases of the central nervous system, in particular those associated with COVID-19. Using this method, an individual profile of serum immunoreactivity is analyzed, depending on changes in the relative content of IgG autoantibodies directed to 12 autogens of the nervous system. The significant number of people who have had COVID-19 among the population of our country, the neurotropism of the coronavirus and the possibility of developing not only early, but also late complications from the nervous system is a prerequisite for a deeper and more comprehensive study of all the most important aspects of COVID-19 associated lesions of the central nervous system.

Maqola ma’lumotlari
MualliflarИноятова Фируза Хидоятовна, Рахматуллаева Гулнора Кутбиддиновна, Вахобова Нигина Анорбековна, Абдувалиев Абдурахмон Рустам угли, Миркомилов Элдор Миркодир угли, Салиходжаева Умида Шакировна, Каримов Зохид Бахтиёрович, Исмоилов Хаётжон Уктамжон угли, Султонов Эркин Ёкубжон угли
JurnalЖурнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research
Nashr sanasi2022-01-06
Jild2
Son4
TilO‘zbek

Kalit so‘zlar

COVID-19, нервная система, нейротропные аутоантитела, ранняя диагностика, COVID-19, nervous system, neurotropic autoantibodies, early diagnosis, COVID-19, асаб тизими, нейротроп аутоантитаналар, эрта ташхислаш

Ilmiy soha

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research jurnalidan boshqa maqolalar

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research — barcha maqolalar